Suppr超能文献

[眼眶减压术治疗内分泌性眼眶病]

[Orbital decompression in treatment of endocrine orbitopathy].

作者信息

Tveten S, Mohr C, Esser J

机构信息

Klinik für Gesichts- und Kieferchirurgie, Universitätsklinikum Essen.

出版信息

Mund Kiefer Gesichtschir. 1998 May;2 Suppl 1:S102-6. doi: 10.1007/PL00014452.

Abstract

Graves' ophthalmopathy (Graves' disease) is a grave, rare immunological inflammatory reaction of the postorbital connective, adipose and ocular muscle tissue. Graves' disease occurs only within the scope of immunothyropathies and constitutes the most frequently encountered extrathyroidal manifestation. Typical symptoms are a result of the volume increase of the postbulbar connective and adipose tissue and of the interstitial swelling of the ocular muscles. Clinically, we find a spectrum of increasingly grave changes in the orbita, such as infiltration of the eyelid and connective tissue, exophthalmos, swelling of the muscles, damage to the cornea and involvement of the optic nerve with loss of vision. Regarding functional impairment of the optic nerve (optic nerve compression), orbita decompression represents an operative ultima ratio. Between January 1992 and April 1997, 11 patients (22 orbitae) from a group of more than 600 patients with Graves' disease with vision involvement were treated surgically. All treatment data were documented prospectively. Surgical intervention was performed only in cases where a progressive loss of vision existed in spite of retrobulbar irradiation and high-dose glucocorticoid therapy. Surgical therapy consisted of decompression of the medial, inferior and lateral orbital wall and of the orbital contents via combined bi-coronary and anterior access. The long-term results demonstrated improved vision conditions with 17 of the 22 eyes operated on. Parameters such as vision, exophthalmos, VEP, motility, double vision and field of vision were documented pre- and post-operatively. The prediction of post-operative deviations of the bulb axis was limited, and these were rectified through secondary displacements of the ocular muscle. No complications worth mentioning were encountered. In extreme events of therapy-resistant Graves' ophthalmopathies with progressive loss of vision, the three-wall decompression method has proved to be the correct one.

摘要

格雷夫斯眼病(格雷夫斯病)是一种严重且罕见的眶后结缔组织、脂肪组织和眼肌组织的免疫性炎症反应。格雷夫斯病仅发生在免疫性甲状腺疾病范围内,是最常见的甲状腺外表现。典型症状是球后结缔组织和脂肪组织体积增加以及眼肌间质肿胀的结果。临床上,我们发现眼眶存在一系列日益严重的变化,如眼睑和结缔组织浸润、眼球突出、肌肉肿胀、角膜损伤以及视神经受累导致视力丧失。关于视神经功能损害(视神经受压),眼眶减压是最后的手术手段。1992年1月至1997年4月,在600多名患有格雷夫斯病且视力受累的患者中,有11名患者(22只眼眶)接受了手术治疗。所有治疗数据均进行了前瞻性记录。仅在尽管进行了球后照射和高剂量糖皮质激素治疗但仍存在视力进行性丧失的情况下才进行手术干预。手术治疗包括通过双冠状切口和前路联合进行眼眶内侧壁、下壁和外侧壁以及眶内容物的减压。长期结果显示,接受手术的22只眼中有17只视力状况得到改善。术前和术后记录了视力、眼球突出度、视觉诱发电位、眼球运动、复视和视野等参数。眼球轴术后偏差的预测有限,这些偏差通过眼肌的二次移位得到纠正。未遇到值得一提的并发症。在治疗抵抗性格雷夫斯眼病伴有进行性视力丧失的极端情况下,三壁减压法已被证明是正确的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验